Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,145 public trials 553 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex

NCT00000675

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: Stanford Univ School of Medicine Stanford, California, United States

Univ of Washington Seattle, Washington, United States

View Trial Details

Completed

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

NCT00002184

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Phoenix Body Positive Phoenix, Arizona, United States

Krauss Med Partners / Dept of Research and Development Los Angeles, California, United States

UCLA Care Ctr Los Angeles, California, United States

Davies Med Ctr San Francisco, California, United States

View all 15 locations

View Trial Details

Completed

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

NCT00002183

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: UCSD San Diego, California, United States

Univ of Colorado Health Sciences Ctr Denver, Colorado, United States

AIDS Research Consortium of Atlanta Atlanta, Georgia, United States

View Trial Details

Completed

A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

NCT00002442

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: AIDS Healthcare Foundation Los Angeles, California, United States

Palo Alto Veterans Affairs Health Care System Palo Alto, California, United States

Dupont Circle Physicians Group Washington D.C., District of Columbia, United States

IDC Research Initiative Altamonte Springs, Florida, United States

View Trial Details

Completed

The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients

NCT00002385

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

NCT00002216

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Anderson Clinical Research Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients

NCT00002030

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +25 more
Locations: Fisons Corp Rochester, New York, United States

View Trial Details

Completed

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

NCT00002084

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Anus Diseases, +32 more
Locations: Univ of South Alabama Mobile, Alabama, United States

Univ of Arizona / Health Science Ctr Tucson, Arizona, United States

Combat Group Los Angeles, California, United States

Los Angeles County - USC Med Ctr Los Angeles, California, United States

View all 46 locations

View Trial Details

Completed

A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients

NCT00002350

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Univ of Pennsylvania Med Ctr Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia

NCT00001991

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
Locations: Glaxo Wellcome Inc Research Triangle Park, North Carolina, United States

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions